Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 11.50
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.696%)
Open: 12.00
High: 12.75
Low: 12.00
Prev. Close: 12.00
SOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM

4 Mar 2011 11:20

RNS Number : 3572C
Medavinci PLC
04 March 2011
 



 

MedaVinci plc

("MedaVinci" or the "Company")

Result of General Meeting, Readmission, Change of Name to Orogen Gold Plc and

Approval for the Reopening of Access to Historic Mines at the Deli Jovan Gold Project

 

 

Result of General Meeting and Change of Name to Orogen Gold plc

 

Further to the announcement on 16 February 2011, and the admission document of the same date, the Board is pleased to announce that, at the General Meeting held earlier today, all resolutions, including those resolutions relating to the acquisition of remaining 51 per cent of Orogen Gold Limited and the change of name to Orogen Gold Plc, were duly passed by Shareholders.

 

The name change to Orogen Gold Plc (ORE.L) and readmission of the Company's entire issued share capital to AIM are expected to become effective at 8.00 am on 7 March 2011.

 

Board Changes

 

Conditional upon Admission, John Barry, Ed Slowey and Alan Mooney will be appointed to the Board as Chairman, Chief Executive Officer and Finance Director respectively and Paul Foulger, Michael Hough and Glyn Hirsch will step down from the Board. Paul Foulger will continue working with the Company as Company Secretary.

 

Approval for the Reopening of Access to Historic Mines at the Deli Jovan Gold Project

 

The Company is also pleased to report that the plan for the re-opening of access to the historic gold mines at Rusman and Gindusa at the Deli Jovan Gold Project has now been approved by the Serbian Ministry of Mining and Energy. Deli Jovan Exploration d.o.o. ("DE"), the joint venture company in which Orogen Gold Limited has the right to earn an interest pursuant to the Earn in Agreement, will now appoint a local contractor to commence the rehabilitation of the old mine workings which will facilitate detailed mapping and sampling of the workings.

 

The planned DE underground and surface exploration programme is aimed at demonstrating the continuity and grade of the Deli Jovan mineralisation and obtaining samples for ore processing recovery test work, which will feed into planning for the re-development of this historic gold mining district.

 

Total Voting Rights

 

Following Admission, the Company will have a single class of shares being Ordinary Shares of 0.1 pence each and there will be 1,669,012,453 Ordinary Shares in issue, each carrying one vote per Ordinary Share. The Company does not hold any Ordinary Shares in treasury. The total number of voting rights in the Company's Ordinary Shares will be 1,669,012,453 and this number may be used by shareholders as the denominator in calculations to determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Services Authority's Disclosure and Transparency Rules.

 

Adam Reynolds, Chairman of Medavinci Plc, commented:

 

"I am delighted that shareholders have approved the acquisition of the remaining 51 per cent of Orogen Gold Limited and welcome John Barry, Ed Slowey and Alan Mooney to the Board. The approval for the reopening of the two mines at the Deli Jovan Gold Project is another significant step. We have an exciting gold project in Deli Jovan which I believe will significantly enhance shareholder value."

 

Definitions in this announcement are consistent with those set out in the admission document issued to shareholders of the Company and dated 16 February 2011, a copy of which is available on the Company's website: www.medavinciplc.com. From 7 March 2011, the Company's website address will change to www.orogengold.com, to reflect the change of name.

 

For further information, please contact:

MedaVinci plc

Adam Reynolds/Ed Slowey

Tel: +44 (0) 207 245 1100

 

 

Zeus Capital Limited

Nominated Adviser and Joint Broker

Ross Andrews / Tom Rowley

Tel: +44 (0) 161 831 1512

 

 

XCAP Securities Plc

Joint Broker

John Grant / Karen Kelly / Tim Burge

Tel: +44 (0) 207 101 7070

 

 

Hansard Group

Media Contacts

Nick Nelson / Guy McDougall

Tel: +44 (0) 207 245 1100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGBBGDXCBGBGBS
Date   Source Headline
16th Apr 20247:00 amRNSFull Year Trading Update
10th Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSBoard Changes
12th Dec 20237:00 amRNSHalf Year Results
29th Nov 20237:00 amRNSNotice of Results and Investor Presentations
9th Nov 20237:00 amRNSMello Investor Presentation
18th Oct 20237:00 amRNSTrading & Strategic Update
13th Oct 20237:00 amRNSNotice of Trading Update
5th Oct 20232:25 pmRNSHolding(s) in Company
21st Sep 20231:02 pmRNSResult of AGM
25th Aug 20239:45 amRNSNotice of AGM and Posting of Annual Report
11th Jul 20237:00 amRNSFinal Results
4th Jul 20237:00 amRNSNotice of Results and Investor Presentation
17th Apr 20233:13 pmRNSHolding(s) in Company
13th Apr 20232:28 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTrading Update & Progress on Growth Strategy
16th Mar 20237:00 amRNSAppointment of Interim Non-Executive Chairman
3rd Mar 20238:12 amRNSDirector/PDMR Dealing
17th Feb 20233:54 pmRNSResult of Retail Offer
17th Feb 20237:00 amRNSClose of Retail Offer
14th Feb 20232:51 pmRNSHolding(s) in Company
13th Feb 202311:55 amRNSHolding(s) in Company
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:30 pmRNSResult of Placing
8th Feb 20239:16 amRNSRetail Offer
8th Feb 20237:00 amRNSProposed Placing to raise a minimum of £4 million
6th Feb 20237:00 amRNSDeath of Director
23rd Jan 20237:00 amRNSNew Third Party Arrangement
10th Jan 20237:00 amRNSTrading Update
13th Dec 20227:00 amRNSHalf Year Results
17th Nov 20227:00 amRNSNotice of Results and Investor Presentation
15th Nov 20225:25 pmRNSAIM Rule 17 Schedule 2(g) Update
18th Oct 20227:00 amRNSHalf Year Trading Update
15th Sep 20223:24 pmRNSResult of AGM & Notice of Trading Update
22nd Aug 20227:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20227:00 amRNSBoard Changes and Change of Auditor
12th Jul 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Results and Investor Presentation
10th Jun 20223:31 pmRNSDirector/PDMR Shareholding
6th May 202212:55 pmRNSDirector/PDMR Dealing
14th Apr 20227:00 amRNSBoard Appointment
6th Apr 20222:05 pmRNSSecond Price Monitoring Extn
6th Apr 20222:00 pmRNSPrice Monitoring Extension
6th Apr 20227:00 amRNSTrading Update and New Third Party Arrangements
6th Jan 20227:00 amRNSTrading Update
20th Dec 20219:00 amRNSExercise of Warrants and Total Voting Rights
30th Nov 20217:00 amRNSHalf Year Results
12th Nov 20217:00 amRNSNotice of Results
7th Oct 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.